“Increased age and MELD score at time of transplantation evaluation predicted short-term mortality and only the history of failed alcohol rehab predicted long-term death. “Even the best-case scenario, where we assume patients with follow-up missing data are recompensated, the probability of 1-year alive compensated is only 33%. “Among patients even with clinical improvement who were declined for transplantation, the probability of being alive compensated is only 20% at 1 year and being alive decompensated is 60% at 1 year,” Hsu concluded. Median MELD scores at 1 month, 3 months, 6 months and 1 year were 28, 26, 15 and 12 among survivors. Multivariable analysis showed lower MELD-Na (adjusted OR = 0.8) and absence of grade 3 or 4 hepatic encephalopathy (aOR = 0.02) associated with survival at 3 months 6-month survival associated with lower MELD-Na (aOR = 0.9), stable partnership (aOR = 2) and either private insurance (aOR = 3.4) or Medicare (aOR = 4.7) compared with Medicaid.Īmong patients declined because of clinical improvement, 93% were alive at 6 months but only 15% achieved recompensation. The probability of survival at 3 months, 6 months and 1 year was 58%, 55% and 48%, respectively, and the probability of recompensation at the same time points was 4%, 4% and 6%. El sistema de puntuación MELD utiliza los valores séricos de bilirrubina, creatininay el International normalized ratio(INR) para predecir la supervivencia de los pacientes. The study objective was to identify clinical factors associated with short- and long-term mortality in patients with severe AH patients who were declined for LT.Īccording to study results, the most common reasons patients were declined were psychosocial factors (62%), clinical improvement (16%), medical comorbidities (9%) and finances/insurance (4%). Researchers defined liver recompensation as a MELD score less than 15 without evidence of variceal bleeding, ascites requiring diuretic or overt hepatic encephalopathy requiring medication. All patients had MELD scores greater than 20 (median MELD-Na = 33) with less than 6 months of abstinence at LT evaluation. In a retrospective, multicenter study, Hsu and colleagues analyzed 134 patients (median age, 49 years 57% men) with severe alcohol-associated hepatitis (AH) from five American Consortium of Early Liver Transplantation for Alcohol-Associated Hepatitis (ACCELERATE-AH) sites who were evaluated and declined for early LT from 2012 to 2021. However, organ transplant is a scarce resource.” UNOS policies for indications for transplantation for severe alcohol-associated hepatitis,” Christine Hsu, MD, assistant professor at Georgetown University, said, “Our group has shown that there are generally good outcomes for liver transplantation for severe alcohol-associated hepatitis with a 1-year survival of 94% and an estimated 3-year survival of 84%. “Early liver transplantation for severe alcohol-associated hepatitis is controversial. LONDON - Lower MELD score predicted short- and long-term survival in patients with severe alcohol-associated hepatitis who were declined for early liver transplantation, according to research presented at the International Liver Congress. If you continue to have this issue please contact to Healio

Meld score